Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
about
Cancer genome landscapesThe splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancersMolecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted TherapySpliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesisDefects in spliceosomal machinery: a new pathway of leukaemogenesisFrom human genome to cancer genome: the first decadeEngineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Connections between TET proteins and aberrant DNA modification in cancerEvolutionary conservation and expression of human RNA-binding proteins and their role in human genetic diseaseMyeloid malignancies: mutations, models and managementEmerging patterns of somatic mutations in cancerCancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary ComplexU2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.SF3B1 mutations in chronic lymphocytic leukemia.Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutationsEmerging concepts of epigenetic dysregulation in hematological malignanciesDefective control of pre-messenger RNA splicing in human diseaseThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionMapping the hallmarks of lung adenocarcinoma with massively parallel sequencingNOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AMLHow do messenger RNA splicing alterations drive myelodysplasia?The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers.The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaFollicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSHTargeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.What are we learning from the cancer genome?Cancer genomics and pathology: all together now.Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationKinetic competition during the transcription cycle results in stochastic RNA processing.An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthThe spliceosome is a therapeutic vulnerability in MYC-driven cancer.Functional study of one nucleotide mutation in pri-miR-125a coding region which related to recurrent pregnancy loss.Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
P2860
Q22242276-1D9CD4F9-2DFF-48FD-9E58-2D79C527E3FCQ24302434-75FAA3B0-5A05-465D-8BB5-594A1FD062E7Q26749870-D8FF7658-CB26-4753-A4F7-8AE9D0247402Q26752221-1B2EB091-1C99-4A69-86BC-4D82FD391ED4Q26823040-04C43A37-194B-42A0-B72D-0F96BC53C54BQ26827640-50E898A4-E21E-42B5-87EB-02CD61D3DC6BQ26828777-3E0B2621-4FA0-46E3-AE11-724FEC8483C8Q26865671-9E8F050B-A507-4D29-9BAD-2E6C7AF1084EQ26991754-BA83659F-C91A-4C85-B479-F0A0CEB355A6Q27000577-C4C7A791-1ADC-41C7-B3EE-B3A2AB55F641Q27014126-42F96C5C-1440-4954-BE83-87FA8001C47EQ27683637-3D856974-AD79-4F46-BFA6-75F00832A6D1Q27851921-1D88D560-8939-4F5A-8704-8A4C260BFAD8Q27852162-BAD365CE-0694-46C7-8904-20874F0F601BQ27852437-8469ABC3-CE01-48A4-BD02-8C4171D0FEFDQ27853094-3F742BD3-62A3-41BA-8E2B-78E0415BA139Q28074522-C95D9649-1B3F-4709-885F-4D2D2D198CDFQ28077564-1D24A7A3-B551-4B55-8A4B-0F02DC1F3A46Q28083838-0190C022-175A-4AF6-A694-BC90F7F1A5DBQ28275103-854897CA-1A4E-48C9-BC97-2932EB35F317Q33556923-8C2395DF-EACF-46AC-887B-0CBFC482FBBDQ33640195-5309AFC2-EB00-489C-BAC5-60D231607FDBQ33746465-385B1C40-54FE-4B80-B215-3D403AD490CCQ33767762-39163B1D-F0BB-49E1-938C-3D9D9BE072F6Q33796552-1417BC12-A4D2-4697-9C72-59A422FCD93EQ33810850-CF4EA684-62DB-4A8B-A1B3-12E4F39A408EQ34047259-F06DF379-781F-44CB-A3B0-1232D0777EE5Q34047994-E5AB9246-4860-49D4-AC38-3C9D6329F490Q34213994-79A91F6C-EBF4-4BA5-BA59-37FF8A6FE30EQ34301519-CCAB49EC-A1E0-4686-8D6A-880A6A5640CCQ34311583-731E0CA6-0E80-41C3-8E69-613C42580D3FQ34348631-CAC579A0-F0D2-4652-9765-1C2B0684FB02Q34396189-286E311E-8AF3-48B3-856F-B7923798617AQ34411315-CB329B27-15AA-4F7B-9484-1D831E48B465Q34418393-E9EB0B29-78C7-470F-B7A3-D54E79914672Q34492012-AF2C55EF-2363-4A86-A33E-7034D2118B94Q34640898-4DB57F4A-2609-4D6F-97C8-A88D57DA4A49Q34667249-D780A363-FFCB-4B67-BB45-AC6099C4F5C6Q35148150-3185DF11-581B-46E0-8536-23D279042C10Q35348356-FDE1B400-0E00-4304-BCE9-DAF3CDD8FFF3
P2860
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@ast
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@en
type
label
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@ast
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@en
prefLabel
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@ast
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@en
P2093
P2860
P356
P1433
P1476
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
@en
P2093
Cara L Lunn
Christopher C Harris
Daniel C Koboldt
Daniel C Link
David E Larson
David J Dooling
Elaine R Mardis
Heather Schmidt
P2860
P2888
P356
10.1038/NG.1031
P407
P577
2011-12-11T00:00:00Z